Discovery of Alternative Producers of the Enediyne Antitumor Antibiotic C-1027 with High Titers

Xiaohui Yan, Hindra, Huiming Ge, Dong Yang, Tingting Huang, Ivana Crnovcic, Chin-Yuan Chang, Shi Ming Fang, Thibault Annaval, Xiangcheng Zhu, Yong Huang, Li Xing Zhao, Yi Jiang, Yanwen Duan, Ben Shen*


研究成果: Article同行評審

12 引文 斯高帕斯(Scopus)


The potent cytotoxicity and unique mode of action make the enediyne antitumor antibiotic C-1027 an exquisite drug candidate for anticancer chemotherapy. However, clinical development of C-1027 has been hampered by its low titer from the original producer Streptomyces globisporus C-1027. Here we report three new C-1027 alternative producers, Streptomyces sp. CB00657, CB02329, and CB03608, from The Scripps Research Institute actinomycetes strain collection. Together with the previously disclosed Streptomyces sp. CB02366 strain, four C-1027 alternative producers with C-1027 titers of up to 11-fold higher than the original producer have been discovered. The five C-1027 producers, isolated from distant geographic locations, are distinct Streptomyces strains based on morphology and taxonomy. Pulsed-field gel electrophoresis and Southern analysis of the five C-1027 producers reveal that their C-1027 biosynthetic gene clusters (BGCs) are all located on giant plasmids of varying sizes. The high nucleotide sequence similarity among the five C-1027 BGCs implies that they most likely have evolved from a common ancestor.

頁(從 - 到)594-599
期刊Journal of Natural Products
出版狀態Published - 23 3月 2018


深入研究「Discovery of Alternative Producers of the Enediyne Antitumor Antibiotic C-1027 with High Titers」主題。共同形成了獨特的指紋。